» Articles » PMID: 38333215

DAMPs and Radiation Injury

Overview
Journal Front Immunol
Date 2024 Feb 9
PMID 38333215
Authors
Affiliations
Soon will be listed here.
Abstract

The heightened risk of ionizing radiation exposure, stemming from radiation accidents and potential acts of terrorism, has spurred growing interests in devising effective countermeasures against radiation injury. High-dose ionizing radiation exposure triggers acute radiation syndrome (ARS), manifesting as hematopoietic, gastrointestinal, and neurovascular ARS. Hematopoietic ARS typically presents with neutropenia and thrombocytopenia, while gastrointestinal ARS results in intestinal mucosal injury, often culminating in lethal sepsis and gastrointestinal bleeding. This deleterious impact can be attributed to radiation-induced DNA damage and oxidative stress, leading to various forms of cell death, such as apoptosis, necrosis and ferroptosis. Damage-associated molecular patterns (DAMPs) are intrinsic molecules released by cells undergoing injury or in the process of dying, either through passive or active pathways. These molecules then interact with pattern recognition receptors, triggering inflammatory responses. Such a cascade of events ultimately results in further tissue and organ damage, contributing to the elevated mortality rate. Notably, infection and sepsis often develop in ARS cases, further increasing the release of DAMPs. Given that lethal sepsis stands as a major contributor to the mortality in ARS, DAMPs hold the potential to function as mediators, exacerbating radiation-induced organ injury and consequently worsening overall survival. This review describes the intricate mechanisms underlying radiation-induced release of DAMPs. Furthermore, it discusses the detrimental effects of DAMPs on the immune system and explores potential DAMP-targeting therapeutic strategies to alleviate radiation-induced injury.

Citing Articles

The Extra-Tumoral Vaccine Effects of Apoptotic Bodies in the Advancement of Cancer Treatment.

Wang Y, Liu C, Pang J, Li Z, Zhang J, Dong L Small. 2025; 21(9):e2410503.

PMID: 39871756 PMC: 11878267. DOI: 10.1002/smll.202410503.


Combination Immunotherapy With Radiotherapy in Non-Small Cell Lung Cancer: A Review of Evidence.

Burr J, Johnson K, Carmicheal J, Lin C, Ganti A Cancer Med. 2024; 13(21):e70402.

PMID: 39526426 PMC: 11551781. DOI: 10.1002/cam4.70402.


Emerging roles of tRNA-derived small RNAs in injuries.

Wang M, Guo J, Chen W, Wang H, Hou X PeerJ. 2024; 12:e18348.

PMID: 39465146 PMC: 11512806. DOI: 10.7717/peerj.18348.


A comprehensive review of sensors of radiation-induced damage, radiation-induced proximal events, and cell death.

Saini S, Gurung P Immunol Rev. 2024; 329(1):e13409.

PMID: 39425547 PMC: 11742653. DOI: 10.1111/imr.13409.


Mechanisms of radiation-induced tissue damage and response.

Zhou L, Zhu J, Liu Y, Zhou P, Gu Y MedComm (2020). 2024; 5(10):e725.

PMID: 39309694 PMC: 11413508. DOI: 10.1002/mco2.725.


References
1.
Borjas T, Jacob A, Yen H, Patel V, Coppa G, Aziz M . Inhibition of the Interaction of TREM-1 and eCIRP Attenuates Inflammation and Improves Survival in Hepatic Ischemia/Reperfusion. Shock. 2021; 57(2):246-255. PMC: 8758526. DOI: 10.1097/SHK.0000000000001894. View

2.
Wu D, Han R, Deng S, Liu T, Zhang T, Xie H . Protective Effects of Flagellin A N/C Against Radiation-Induced NLR Pyrin Domain Containing 3 Inflammasome-Dependent Pyroptosis in Intestinal Cells. Int J Radiat Oncol Biol Phys. 2018; 101(1):107-117. DOI: 10.1016/j.ijrobp.2018.01.035. View

3.
Denning N, Aziz M, Murao A, Gurien S, Ochani M, Prince J . Extracellular CIRP as an endogenous TREM-1 ligand to fuel inflammation in sepsis. JCI Insight. 2020; 5(5). PMC: 7141396. DOI: 10.1172/jci.insight.134172. View

4.
Merline R, Moreth K, Beckmann J, Nastase M, Zeng-Brouwers J, Tralhao J . Signaling by the matrix proteoglycan decorin controls inflammation and cancer through PDCD4 and MicroRNA-21. Sci Signal. 2011; 4(199):ra75. PMC: 5029092. DOI: 10.1126/scisignal.2001868. View

5.
Yang H, Wang H, Andersson U . Targeting Inflammation Driven by HMGB1. Front Immunol. 2020; 11:484. PMC: 7099994. DOI: 10.3389/fimmu.2020.00484. View